Efficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer

Published:2015-08 Issue:31 Volume:94 Page:e1282
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Sheng Jin,Yang Yun-Peng,Yang Bi-Jun,Zhao Yuan-Yuan,Ma Yu-Xiang,Hong Shao-Dong,Zhang Ya-Xiong,Zhao Hong-Yun,Huang Yan,Zhang Li

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference37 articles.

1. Cancer statistics, 2014.;Siegel;CA Cancer J Clin,2014

2. Non-small cell lung cancer.;Ettinger;J Natl Compr Canc Netw,2012

3. Erlotinib in previously treated non-small-cell lung cancer.;Shepherd;N Engl J Med,2005

4. Treatment paradigms for patients with metastatic non-small-cell lung cancer: first-, second-, and third-line.;Leighl;Curr Oncol,2012

5. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.;Hicklin;J Clin Oncol,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of reported claims of sex-based differences in treatment effects across meta-analyses: A meta-research study;2024-07-10

2. Anti-angiogenic agents for NSCLC following first-line immunotherapy: Rationale, recent updates, and future perspectives;Lung Cancer;2023-05

3. ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA;European Journal of Cancer;2022-05

4. 99mTc-3PRGD2 SPECT Predicts the Outcome of Endostar and Cisplatin Therapy in Xenograft Animals;Dose-Response;2019-10-01

5. Integrin αVβ3‑targeted SPECT/CT for the assessment of Bevacizumab therapy in orthotopic lung cancer xenografts;Oncology Letters;2018-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3